Separating the wheat from the chaff—COVID-19 in a German emergency department: a case-control study
Autor: | Carola Holzner, Sebastian Dolff, Joachim Risse, Benedikt Michael Schaarschmidt, Lale Umutlu, David Fistera, Dirk Pabst, Annalena Härtl, Clemens Kill |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Isolation (health care) SARS-Cov-2 Medizin Disease 03 medical and health sciences 0302 clinical medicine Health care medicine 030212 general & internal medicine ddc:610 Original Research business.industry Emergency department Case-control study lcsh:Medical emergencies. Critical care. Intensive care. First aid COVID-19 030208 emergency & critical care medicine lcsh:RC86-88.9 Triage Dysgeusia Clinical trial Medizinische Fakultät » Universitätsklinikum Essen » Zentrum für Notfallmedizin Medizinische Fakultät » Universitätsklinikum Essen » Institut für Diagnostische und Interventionelle Radiologie und Neuroradiologie Emergency medicine Emergency Medicine medicine.symptom Clinical symptoms business |
Zdroj: | International Journal of Emergency Medicine, Vol 13, Iss 1, Pp 1-9 (2020) International Journal of Emergency Medicine |
ISSN: | 1865-1380 1865-1372 |
Popis: | Background COVID-19 pandemia is a major challenge to worldwide health care systems. Whereas the majority of disease presents with mild symptoms that can be treated as outpatients, severely ill COVID-19 patients and patients presenting with similar symptoms cross their ways in the emergency department. Especially, the variety of symptoms is challenging with primary triage. Are there parameters to distinguish between proven COVID-19 and without before? How can a safe and efficient management of these inpatients be achieved? Methods We conducted a retrospective analysis of 314 consecutive inpatient patients who presented with possible symptoms of COVID-19 in a German emergency department between March and April 2020 and were tested with a SARS-Cov-2 nasopharyngeal swab. Clinical parameters, Manchester Triage System categories, and lab results were compared between patients with positive and negative test results for SARS-Cov-2. Furthermore, we present the existing COVID-19 workflow model of the university hospital in Essen which proved to be efficient during pandemia. Results Forty-three of the 314 patients (13.7%) were tested positive for COVID-19 by SARS-Cov-2 nasopharyngeal swab. We did not find any laboratory parameter to distinguish safely between patients with COVID-19 and those with similar symptoms. Dysgeusia was the only clinical symptom that was significantly more frequent among COVID-19 patients. Conclusion Dysgeusia seems to be a typical symptom for COVID-19, which occurred in 14% of our COVID-19 patients. However, no valid parameters could be found to distinguish clinically between COVID-19 and other diseases with similar symptoms. Therefore, early testing, a strict isolation policy, and proper personal protection are crucial to maintain workflow and safety of patients and ED staff for the months to come. Trial registration German Clinical Trials registry, DRKS00021675 |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |